SynthesisAntimicrobial resistance and infection control2026
Antimicrobial locks for the prevention of central line associated bloodstream infections in pediatric patients: a systematic review and network meta-analysis.
Synthesis in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCentral-line-associated bloodstream infections (CLABSI) impart substantial morbidity and mortality worldwide Neonates and other pediatric patients with chronic conditions that require long-term central access are at the highest risk and often develop CLABSIs despite high compliance with evidence-based prevention bundles. One potential adjunctive prevention strategy is the use of antimicrobial locks; however, data concerning the effectiveness of locks in preventing pediatric CLABSIs are mixed.
methodsWe conducted a systematic review of randomized controlled trials and, separately, observational studies of pediatric patients who received antimicrobial locks for primary and secondary CLABSI prevention since antimicrobial locks were described in 1990. We conducted meta-analyses for both study designs to evaluate the effectiveness of antimicrobial locks in reducing CLABSIs.
resultsThirty-five studies were included in the systematic review; twenty-six studies were included in the meta-analyses. Among the 11 randomized controlled trials eligible for inclusion in the meta-analysis, there was a 48% lower rate of CLABSIs in those with antimicrobial locks than in those with standard locks (pooled IRR: 0.52 (p = 0.016, [95% CI 0.317, 0.86], I
conclusionsThis review highlights the need for well-designed studies to determine the clinical effectiveness of antimicrobial locks for primary and secondary CLABSI prevention in specific pediatric populations and to determine whether there is differential impact by lock type.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.